Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors

Clinical Cancer Research

Volumn 10, Issue 16, 2004, Pages 5349-5354

  Parrella, Paola ^a,g   Poeta, Maria Luana ^b   Gallo, Antonietta Pia ^a   Prencipe, Maria ^a   Scintu, Marina ^a   Apicella, Adolfo ^c   Rossiello, Raffaele ^c   Liguoro, Giuseppina ^c   Seripa, Davide ^a   Gravina, Carolina ^a   Rabitti, Carla ^b   Rinaldi, Monica ^d   Nicol, Theresa ^e   Tommasi, Stefania ^f   Paradiso, Angelo ^f   Schittulli, Francesco ^f   Altomare, Vittorio ^b   Fazio, Vito Michele ^a,b  

^a Ist Ricovero/Cura Carattere Sci   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d CNR   (Italy)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^g Ist Ricovero/Cura Carattere Sci   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BISULFATE SODIUM; BISULFITE; BRCA1 PROTEIN; GENE PRODUCT; GENOMIC DNA; PROTEIN P16; UNCLASSIFIED DRUG;

ARTICLE; BENIGN TUMOR; BREAST CANCER; BREAST TUMOR; CCND2 GENE; CDH1 GENE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DNA METHYLATION; ESR1 GENE; GENE; GENE FREQUENCY; GENE LOCUS; GSTP1 GENE; HIC1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; RARBETA2 GENE; TRBETA1 GENE;

ANALYSIS OF VARIANCE; BREAST NEOPLASMS; DINUCLEOSIDE PHOSPHATES; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS);

EID: 4143089298     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0555     Document Type: Article

References (34)

1. Bundred NJ Prognostic and predictive factors in breast cancer. Cancer Treat Rev 2001;27:137-42.
2. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000;16:168-74.
3. Costello JF, Fruhwald C, Smiraglia DJ, et al. Aberrant CpG island methylation as nonrandom and tumor type specific patterns. Nat Genet 2000;24:132-8.
4. Esteller M, Com PG, Baylin SB, Herman, JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-9.
5. Keen JC, Davidson NE. The biology of breast carcinoma. Cancer 2003;97:825-33.
6. Esteller M, Sparks A, Toyota M, et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 2000;60:4366-71.
7. Ilyas M, Tomlison IP. The interaction of APC, E-cadherin and beta-catenin in tumor development and progression. J Pathol 1997;182:128-37.
8. Zhang P. The cell Cycle and development: redundant roles of cell cycle regulators. Curr Opin Cell Biol 1999;11:655-62.
9. Daniel V. Glutathione-S-transferases: gene structure and regulation of expression. Crit Rev Biochem Mol 1993;28:173-207.
10. Welcsh P, King MC. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet 2001;10:705-13.
11. Chen WY, Zeng X, Carter MG, et al. Heterozygous distruption of HIC1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat Genet 2003;33:197-202.
12. Ferguson AT, Lapidus R, Baylin S, Davidson NE. Demethylation of the estrogen receptor gene in estrogen receptor negative breast cancer cells can reactivate estrogen receptor gene espression. Cancer Res 1995;55:2279-83.
13. Ferguson AT, Vertino P, Spitzner J, Baylin SB, Muller M, Davidson NE. Role of etrogen receptor gene demethylationj and DNA-methyltransferase-DNA adduct formation in 5-aza-2′-cytotoxicity in human breast cancer cells. J Biol Chem 1997;272:32260-6.
14. Yang X, Phillips DL, Ferguson AT, Nelson WG, Herman JG, Davidson NE. Synergistic activation of functional estrogen receptor (ER) by DNA methyltransferase and hystone deacetylase in human Erα negative breast cancer cells. Cancer Res 2001;61:7025-9.
15. Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, et al. Detection of mitochondrial DNA mutations in primary breast cancer and fine needle aspirates. Cancer Res 2001;61:7623-6.
16. Parrella P, Sidransky D, Merbs SL. Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway. Cancer Res 1999;59:3032-7.
17. Olek A, Oswald J, Walter JA modified and improved method of bisulfitr based cytosine methylation analysis. Nucleic Acid Res 1996; 24:5064-6.
18. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-6.
19. Lapidus RG, Nass SJ, Butash KA, et al. Mapping of ER Gene CpG island by methylation specific polymerase chain reaction. Cancer Res 1998;58:2515-9.
20. Cairns P, Esteller M, Herman JG., et al. Molecular detection of prostate cancer in urine by GSTP1 hypermetylation. Clin Cancer Res 2001;7:2727-30.
21. Esteller M, Silva JM, Dominguez G, et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 2000;92:564-9.
22. Widschwendter M, Berger J, Hermann M, et al. Methylation and silencing of receptor-β2 gene in breast cancer. J Natl Cancer Inst 2000;92:826-32.
23. Li Z, Meng ZH, Chandrasekaran R, et al. Biallelic inactivation of the thyroid hormone receptor β1 gene in early stage breast cancer. Cancer Res 2002;62:1939-43.
24. Dong SM, Kim HS, Rha SH, Sidransky D. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 2001;7:1982-6.
25. Evron E, Umbricht CB, Korz D, et al. Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res 2001;61:2782-7.
26. Strathdee G, Appleton K, Illand M, et al. Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes. Am J Pathol 2001;158:1121-7.
27. Nass SJ, Herman JG, Gabrielson E, et al. Aberrant methylation of the estrogen receptor and E-cadherin 5′ CPG islands increases with malignant progression in human breast cancer. Canc Res 2000;60: 4346-8.
28. Esteller M, Fraga MF, Guo M, et al. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Molec Genet 2001;10:3001-7.
29. Jeronimo C, Costa I, Martins MC et al. Detection of gene promoter hypermethylation in fine needle washings from breast lesions. Clin Cancer Res 2003;9:3413-7.
30. Johnston SR, Saccani-Jotti G, Smith IE, et al. Changes in estrogen receptor, progesterone receptor and pS2 expression in tamoxifen-resistant breast cancer. Cancer Res 1995;55:3331-8.
31. Kos M, Reid G, Denger S, Gannon F. Minireview: Genomic organization of the human ERα gene promoter region. Mol Endocrinol 2001;15:2057-63.
32. Ponglikitmongkol M, Green S, Chambon P. Genomic organization of the human oestrogen receptor gene. EMBO J 1988;7:3385-8.
33. Muller HM, Widschwendter A, Fiegl H, et al. DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res 2003;63:7641-5.
34. Van Rijnsoever M, Elsaleh H, Joseph D, McCaul K, Iacopetta B, CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage II colorectal cancer. Clin Cancer Res 2003;9:2898-903.